MetLife, Inc. with ticker code (MET) now have 14 analysts in total covering the stock. The consensus rating is pointing to ‘Buy’. The range between the high target price and low target price is between 86 and 60 and has a mean target at $76.64. Now with the previous closing price of $59.21 and the analysts are correct then there would likely be a percentage uptick in value of 29.4%. Also worth taking note is the 50 day moving average now sits at $62.58 and the 200 day MA is $67.13. The company has a market capitalization of $45,625m. Visit the company website at: https://www.metlife.com
The potential market cap would be $59,056m based on the market consensus.
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it provides fixed, indexed-linked, and variable annuities; pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity reinsurance solutions; credit insurance products; and protection against long-term health care services. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.
The company has a dividend yield of 3.53% with the ex dividend date set at 8-5-2023 (DMY).
Other points of data to note are a P/E ratio of 20.25, revenue per share of 87.02 and a 0.33% return on assets.
